Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Apix Biosciences NV Aka Apix Bioscience holds a patent portfolio in the Chemistry & Materials technology area with a very specific prosecution footprint. The data shows 1 pending office action currently in the system. This action is being handled by 1 distinct examiner, suggesting that the company's current patenting efforts are focused on a single technical advancement or a very narrow set of claims.
The entirety of the pending workload is situated within 1 distinct art unit. RODGERS, ARIEL M is the busiest examiner for the portfolio, with 1 busiest examiner pending office action currently assigned. Since the total number of pending office actions is 1, this examiner manages the full extent of the company's active prosecution. This concentration allows for a dedicated focus on the requirements of 1 distinct art unit, though it limits the portfolio's current activity to the pace and feedback of a specific examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODGERS, ARIEL M | 1 | 15.4% | +26.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18222010 | BEE NUTRITION | RODGERS, ARIEL M | 70d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18222010 | BEE NUTRITION | RODGERS, ARIEL M | 70d overdue |
| Art Unit | Apps |
|---|---|
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18222010 | BEE NUTRITION | RODGERS, ARIEL M | 1792 | §103 | Final Rejection | 70d overdue | Pending | Jul 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialApix Biosciences NV Aka Apix Bioscience has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ariel M Rodgers has the most, with 1 of Apix Biosciences NV Aka Apix Bioscience's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
